Source: Eur Respir J 2003; 21: 241-247
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
Logan A.G., Tkacova R., Perlikowski S.M., Leung R.S., Tisler A., Floras J.S., Bradley T.D.. Refractory hypertension and sleep apnoea: effect of CPAP on blood pressure and baroreflex. Eur Respir J 2003; 21: 241-247

Member's Comments

No comment yet.

Related content which might interest you: Baroreflex control of heart rate during sleep in severe obstructive sleep apnoea: effects of acute CPAP Source: Eur Respir J 2006; 27: 128-135 Year: 2006 CPAP and measures of cardiovascular risk in males with OSAS Source: Eur Respir J 2008; 32: 1488-1496 Year: 2008 Exacerbation of sleep-apnoea related nocturnal blood-pressure fluctuations in hypertensive subjects Source: Eur Respir J 2002; 20: 151-157 Year: 2002 Blood pressure responsiveness to obstructive events during sleep after chronic CPAP Source: Eur Respir J 2003; 21: 509-514 Year: 2003 Sympathetic activity is reduced by nCPAP in hypertensive obstructive sleep apnoea patients Source: Eur Respir J 2004; 23: 255-262 Year: 2004 14 nights of intermittent hypoxia elevate daytime blood pressure and sympathetic activity in healthy humans Source: Eur Respir J 2011; 37: 119-128 Year: 2011 Early changes in blood pressure, vascular and heart function in obstructive sleep apnoea (OSA). Impact of treatment Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment Year: 2007 Cardiovascular regulation effects of CPAP therapy in obstructive sleep apnea patients with and without hypertension during daytime Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II Year: 2012 Ventilatory support and pharmacological treatment of patients with central apnoea or hypoventilation during sleep Source: Eur Respir Rev 2007; 16: 115-124 Year: 2007 Cardiovascular and metabolic effects of CPAP in obese males with OSA Source: Eur Respir J 2007; 29: 720-727 Year: 2007 Should obstructive sleep apnoea be treated regarding the related cardiovascular risk in non sleepy patients? Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases Year: 2006 Management of hypertension in obstructive sleep apnoea: predicting blood pressure reduction under continuous positive airway pressure Source: Eur Respir J, 50 (4) 1701822; 10.1183/13993003.01822-2017 Year: 2017 Sleep-disordered breathing and hormones Source: Eur Respir J 2003; 22: 161-172 Year: 2003 Pathophysiology of obstructive sleep apnoea: from clinical closing pressure to ventilatory Source: International Congress 2019 – PG17 Sleep apnoea and hypoventilation: obstruction and more Year: 2019 Treatment of obstructive and central sleep apnoea in heart failure: current concepts and perspectives Source: Annual Congress 2005 - PG12 - Sleep-related problems: treatment of obstructive sleep apnoea - current concepts and perspectives Year: 2005 Influence of continuous positive airway pressure therapy on endothelial function and blood pressure in patients with arterial hypertension and obstructive sleep apnoea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 814s Year: 2006 Antioxidant status in obstructive sleep apnea: no influence of one night continuous airway pressure therapy Source: Eur Respir J 2006; 28: Suppl. 50, 574s Year: 2006 Effects of continuous positive airway pressure therapy in patients with severe obstructive sleep apnea and endothelial dysfunction on 24-hour blood pressure profile Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing Year: 2015 Cardiac sympathovagal balance during sleep in obstructive sleep apnea patients is different under auto-adjusting CPAP than fixed-CPAP treatment Source: Annual Congress 2006 - Therapeutic effects in obstructive sleep apnoea Year: 2006 Pathophysiology of central sleep apnea Source: Annual Congress 2005 - Central sleep apnoea Year: 2005